Back to search
FDAFDA · Food and drugs·Recall number Z-2228-2018

Part #: SAM XT-C, Model: Hi-Viz Blue

Published June 20, 2018 · Recall initiated: May 2, 2018

Summary

FDA records medical device Class II recall Z-2228-2018, published June 20, 2018 and initiated May 2, 2018. Recalling firm: The Seaberg Company Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot #: XT1808, XT1809, XT1810. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Based on internal testing, results indicated a possible failure of the stitches securing the buckle to the nylon belt could occur, posing a potential risk when used on a human patient to stop arterial blood flow. There is a remote chance that a serious injury and/or death could occur as a result of the failure of the device.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Seaberg Company Inc
Distributor
USA: CA, MD, OH, FL, ID, CO, CT, OR, AZ, IL, ME, MO, NY, SC, MI, AR, MT, CT, WA, TX, KY, NC, NJ, PA OUS: Australia, Canada, China, Columbia, Costa Rica, Europe (EU), Hong Kong, Iceland, India, Iraq, Israel, Japan, Kenya, Korea, Lebanon, Malaysia, Russia, Saudi Arabia, Singapore, South Africa, Thailand, UAE
Lot
Lot #: XT1808, XT1809, XT1810
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Part #: SAM XT-C, Model: Hi-Viz Blue recalled?

Yes. FDA published recall Z-2228-2018 on June 20, 2018. Reported hazard: Based on internal testing, results indicated a possible failure of the stitches securing the buckle to the nylon belt could occur, posing a potential risk when used on a human patient to stop arterial blood flow. There is a remote chance that a serious injury and/or death could occur as a result of the failure of the device.

What should I do if I have this product?

Voluntary: Firm initiated · Letter